
### [NCIT:C6798](http://purl.obolibrary.org/obo/NCIT_C6798)
**Label:** Apocrine Neoplasm

**Subclasses:** [NCIT:C4168](http://purl.obolibrary.org/obo/NCIT_C4168) (Apocrine Adenoma), [NCIT:C4169](http://purl.obolibrary.org/obo/NCIT_C4169) (Apocrine Carcinoma), [NCIT:C5457](http://purl.obolibrary.org/obo/NCIT_C5457) (Invasive Apocrine Breast Carcinoma), [NCIT:C6800](http://purl.obolibrary.org/obo/NCIT_C6800) (Malignant Apocrine Neoplasm), [NCIT:C6799](http://purl.obolibrary.org/obo/NCIT_C6799) (Benign Apocrine Neoplasm), [NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma), [NCIT:C27527](http://purl.obolibrary.org/obo/NCIT_C27527) (Tubular Apocrine Adenoma), [NCIT:C43342](http://purl.obolibrary.org/obo/NCIT_C43342) (Apocrine Hidrocystoma), [NCIT:C5140](http://purl.obolibrary.org/obo/NCIT_C5140) (Apocrine Breast Carcinoma In Situ), [NCIT:C5141](http://purl.obolibrary.org/obo/NCIT_C5141) (Apocrine Breast Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C62494](http://purl.obolibrary.org/obo/NCIT_C62494) (Neoplastic Apocrine Cell) 62.50%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) 58.33%
- [NCIT:C36908](http://purl.obolibrary.org/obo/NCIT_C36908) (Apocrine Carcinoma Cell) 54.17%
- [NCIT:C36118](http://purl.obolibrary.org/obo/NCIT_C36118) (In Situ Lesion) 54.17%
- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 54.17%
- Thing 52.82%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) 39.52%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C38721](http://purl.obolibrary.org/obo/NCIT_C38721) (Nuclear Pleomorphism))) 39.52%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C38710](http://purl.obolibrary.org/obo/NCIT_C38710) (Defective Gamma Heavy Chain Present))) 39.52%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C3870](http://purl.obolibrary.org/obo/NCIT_C3870) (Lymphangitic Carcinomatosis))) 39.52%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C38698](http://purl.obolibrary.org/obo/NCIT_C38698) (Hyperviscosity))) 39.52%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C38674](http://purl.obolibrary.org/obo/NCIT_C38674) (Widespread Disease))) 39.52%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C38667](http://purl.obolibrary.org/obo/NCIT_C38667) (Polymorphic Cellular Infiltrate))) 39.52%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C38666](http://purl.obolibrary.org/obo/NCIT_C38666) (Monomorphic Cellular Infiltrate))) 39.52%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C38665](http://purl.obolibrary.org/obo/NCIT_C38665) (Chest Pain))) 39.52%


